Exact Mass: 474.2076

Exact Mass Matches: 474.2076

Found 500 metabolites which its exact mass value is equals to given mass value 474.2076, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sildenafil

1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate

C22H30N6O4S (474.2049)

Sildenafil is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. It was initially studied for use in hypertension (high blood pressure) and angina pectoris (a form of ischaemic cardiovascular disease). Phase I clinical trials under the direction of Ian Osterloh suggested that the drug had little effect on angina, but that it could induce marked penile erections; Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) which is responsible for degradation of cGMP in the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and acts as a competitive binding agent of PDE5 in the corpus cavernosum, resulting in more cGMP and better erections. Without sexual stimulation, and therefore lack of activation of the NO/cGMP system, sildenafil should not cause an erection. Other drugs that operate by the same mechanism include tadalafil (Cialis) and vardenafil (Levitra); Sildenafil citrate, sold under the names Viagra, Revatio and generically under various other names, is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. Viagra pills are blue and diamond-shaped with the words Pfizer on one side, and VGR xx (where xx stands for 25, 50 or 100, the dose of that pill in milligrams) on the other. Its primary competitors on the market are tadalafil (Cialis), and vardenafil (Levitra). Sildenafil is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Quinapril hydrochloride

Quinapril hydrochloride (Accupril)

C25H31ClN2O5 (474.1921)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

N-[2-(Diacetylamino)-3-(4-isothiocyanatophenyl)propyl]-N-[2-(diacetylamino)propyl]acetamide

N-[2-(N-acetylacetamido)-3-(4-isothiocyanatophenyl)propyl]-N-[2-(N-acetylacetamido)propyl]acetamide

C23H30N4O5S (474.1937)

2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid

2-((2-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1-biphenyl]-3-yl)oxy)acetic acid

C31H26N2O3 (474.1943)

BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells[1][2][3].

Acetyl-arginyl-glycyl-aspartyl-serinamide

3-{[2-({5-carbamimidamido-1-hydroxy-2-[(1-hydroxyethylidene)amino]pentylidene}amino)-1-hydroxyethylidene]amino}-3-{[2-hydroxy-1-(C-hydroxycarbonimidoyl)ethyl]-C-hydroxycarbonimidoyl}propanoate

C17H30N8O8 (474.2186)

Ibrutinib metabolite M37

1-{3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}-2,3-dihydroxypropan-1-one

C25H26N6O4 (474.2015)

Mitopodozidum

N-Ethyl-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-2H,5H,6H,7H,8H-naphtho[2,3-D][1,3]dioxole-6-carbohydrazonate

C24H30N2O8 (474.2002)

N-(2-Benzyl-3-((2-amino-4-methylpentyl)dithio)-1-oxopropyl)glycine benzyl ester

3-[(2-Amino-4-methylpentyl)disulphanyl]-2-benzyl-N-[2-(benzyloxy)-2-oxoethyl]propanimidic acid

C25H34N2O3S2 (474.2011)

(1alpha,2alpha,9beta)-1,14-bis(acetyloxy)-9-(benzoyloxy)-2-hydroxydihydro-beta-agarofuran|rel-(3R,5S,5aR,6R,7S,9R,9aS)-5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-5,6,7-triol 6-acetate 5-benzoate

(1alpha,2alpha,9beta)-1,14-bis(acetyloxy)-9-(benzoyloxy)-2-hydroxydihydro-beta-agarofuran|rel-(3R,5S,5aR,6R,7S,9R,9aS)-5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-5,6,7-triol 6-acetate 5-benzoate

C26H34O8 (474.2254)

(1alpha,2alpha,9beta)-2,14-bis(acetyloxy)-9-(benzoyloxy)-1-hydroxydihydro-beta-agarofuran|rel-(3R,5S,5aS,6R,7S,9R,9aS)-5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-5,6,7-triol 7-acetate 5-benzoate

(1alpha,2alpha,9beta)-2,14-bis(acetyloxy)-9-(benzoyloxy)-1-hydroxydihydro-beta-agarofuran|rel-(3R,5S,5aS,6R,7S,9R,9aS)-5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-5,6,7-triol 7-acetate 5-benzoate

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-4-carbamoylbutanamido]butanedioic acid

C18H30N6O9 (474.2074)

sildenafil

Tyr Val Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C22H30N6O6 (474.2227)

Tyr Val His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C22H30N6O6 (474.2227)

Bis(triethoxysilylpropyl) disulfide

C18H42O6S2Si2 (474.1961)

ETHYL 4-(2,4-BIS(BENZYLOXY)-5-ISOPROPYLPHENYL)-2-HYDROXY-4-OXOBUT-2-ENOATE

C29H30O6 (474.2042)

butyl prop-2-enoate,2-methylprop-2-enoic acid,2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid,prop-2-enenitrile

C21H34N2O8S (474.2036)

N-[2-(4-{[4-(Cyclobutylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino}-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-trien-11-yl)-2-oxoethyl]acetamide

C23H25F3N6O2 (474.1991)

Boc-Asn(Trt)-OH

C28H30N2O5 (474.2155)

tributyl-(4-phenylmethoxyphenyl)stannane

C25H38OSn (474.1944)

Boc-D-Asn(Trt)-OH

C28H30N2O5 (474.2155)

MITOPODOZIDE

Naphtho[2,3-d]-1,3-dioxole-6-carboxylicacid,5,6,7,8-tetrahydro-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-,2-ethylhydrazide, (5R,6R,7R,8R)-

C24H30N2O8 (474.2002)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C1331 - Epipodophyllotoxin Compound C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents C1907 - Drug, Natural Product

pf-03814735

N-(2-((1S,4R)-6-((4-(Cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1,2,3,4-tetrahydro-1,4-epiminonaphthalen-9-yl)-2-oxoethyl)acetamide

C23H25F3N6O2 (474.1991)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

2-benzofuran-1,3-dione,2,2-dimethylpropane-1,3-diol,hexanedioic acid,propane-1,3-diol

C22H34O11 (474.2101)

ZD 7155 hydrochloride

C26H27ClN6O (474.1935)

ZD 7155 hydrochloride is an angiotensin II receptor type 1 (AT1 receptor) antagonist.

Native Aspergillus niger Amyloglucosidase

C28H31ClN4O (474.2186)

methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazole-[3,4-c]pyridine-3-carboxylate

C26H26N4O5 (474.1903)

Ibrutinib Impurity 3

C25H26N6O4 (474.2015)

Tibezonium

C28H32N3S2+ (474.2038)

C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

Acetyl-arginyl-glycyl-aspartyl-serinamide

SB-277011 (hydrochloride)

C28H31ClN4O (474.2186)

C26H34O8 (474.2254)

{"Ingredient_id": "HBIN000760","Ingredient_name": "12\u03b2-hydroxyscillirosidin","Alias": "NA","Ingredient_formula": "C26H34O8","Ingredient_Smile": "CC(=O)OC1CC2(C(CC(C3(C2(CCC3C4=COC(=O)C=C4)O)C)O)C5(C1=CC(CC5)O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10692","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

bersaldegenin-3-acetate

C26H34O8 (474.2254)

{"Ingredient_id": "HBIN017933","Ingredient_name": "bersaldegenin-3-acetate ","Alias": "NA","Ingredient_formula": "C26H34O8","Ingredient_Smile": "CC(=O)OC1CC(C2(C3CCC4(C(CCC4(C3CCC2(C1)O)O)C5=COC(=O)C=C5)C)C=O)O","Ingredient_weight": "474.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "21846","PubChem_id": "21768173","DrugBank_id": "NA"}

(2s,3s,6s,7s,9r,10r,12r)-7-hydroxy-3-[(1s,2e)-1-hydroxy-2-methylhex-2-en-1-yl]-12-[(1r,2s)-2-hydroxy-6-methyl-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-6-methyl-5,11,13-trioxatetracyclo[7.5.0.0²,⁶.0¹⁰,¹²]tetradec-1(14)-en-4-one

(2s,3s,6s,7s,9r,10r,12r)-7-hydroxy-3-[(1s,2e)-1-hydroxy-2-methylhex-2-en-1-yl]-12-[(1r,2s)-2-hydroxy-6-methyl-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-6-methyl-5,11,13-trioxatetracyclo[7.5.0.0²,⁶.0¹⁰,¹²]tetradec-1(14)-en-4-one

(2r,3s,6r,7s,9s,10s,12s)-7-hydroxy-3-[(1r,2e)-1-hydroxy-2-methylhex-2-en-1-yl]-12-[(1s,2r,6r)-2-hydroxy-6-methyl-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-6-methyl-5,11,13-trioxatetracyclo[7.5.0.0²,⁶.0¹⁰,¹²]tetradec-1(14)-en-4-one

1-{3-[(3-acetyl-2,4-dihydroxy-6-methoxy-5-methylphenyl)methyl]-2,4,6-trihydroxy-5-(3-methylbutyl)phenyl}-2-methylpropan-1-one

C26H34O8 (474.2254)

2,4,5-tris(acetyloxy)-6-methyl-3-[(2r)-6-methylhept-5-en-2-yl]phenyl (2z)-2-methylbut-2-enoate

C26H34O8 (474.2254)